The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic ...
In a new study on mice, an experimental antibody treatment reduced the lingering after-effects of head injuries.
A new study suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI). By studying the effects of the nasal anti-CD3 in a ...
Are you using your nasal spray correctly? 🤔 A doctor explains the best technique to ensure you're getting the most out of ...
Could football players with a concussion one day be treated with a quick spray up their nose? That could be a possibility one day after a new study found that a monoclonal antibody-based nasal ...
The FDA has approved neffy 1 mg epinephrine nasal spray for treating anaphylaxis and other type 1 allergic reactions in ...
15d
News Medical on MSNNasal spray may offer new hope for traumatic brain injury patientsA new study led by researchers at Mass General Brigham suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI).
WGNO-TV New Orleans on MSN9d
Nasal spray recalled nationwide; risk of infection: FDA(WHTM) — The U.S. Food & Drug Administration (FDA) has announced the voluntary recall of a sinus nasal wash bottle system following a confirmed test result of microbial contamination. According to the ...
A Mass General Brigham-led study in preclinical models suggests that a nasal spray being tested for use in preventing Alzheimer’s disease could also reduce neuroinflammation in traumatic brain ...
The FDA has approved Neffy, a needle-free nasal spray, for children aged 4 and up, providing fast and effective treatment for severe allergic reactions and anaphylaxis.
13d
The Brighterside of News on MSNRevolutionary nasal spray transforms traumatic brain injury treatmentTraumatic brain injury (TBI) remains a major cause of death and long-term disability. Beyond the immediate damage, TBI ...
STATEN ISLAND, N.Y. — The U.S. Food and Drug Administration (FDA) has announced a recall of 89,312 bottles of a popular nasal spray that may cause “adverse” effects. The NasoGel was recalled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results